Semler Scientific, Inc. (SMLR)

Semler Scientific Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	65.88	68.18	56.69	53.03	38.6	32.77
Revenue Growth (YoY)	8.22%	20.28%	6.90%	37.36%	17.81%	52.47%
Cost of Revenue	6.96	6.98	4.25	6.12	3.36	3.66
Gross Profit	58.92	61.2	52.43	46.91	35.25	29.11
Selling, General & Admin	29.93	32.44	30.42	23.68	16.35	15.92
Research & Development	5.28	5.77	4.81	3.78	2.94	2.48
Other Operating Expenses	1.07	1.07	0	0	0	0
Operating Expenses	36.28	39.28	35.23	27.46	19.29	18.4
Operating Income	22.64	21.92	17.2	19.45	15.96	10.71
Other Expense / Income	-2.63	-2.18	-0.49	-0.01	-0.53	0.01
Pretax Income	25.27	24.1	17.69	19.46	16.49	10.7
Income Tax	3.58	3.52	3.37	2.23	2.48	-4.38
Net Income	21.69	20.58	14.33	17.22	14.01	15.08
Net Income Growth	36.11%	43.69%	-16.82%	22.95%	-7.14%	200.84%
Shares Outstanding (Basic)	7	7	7	7	7	6
Shares Outstanding (Diluted)	8	8	8	8	8	8
Shares Change	-1.44%	-2.26%	-1.71%	0.89%	0.46%	5.25%
EPS (Basic)	3.20	3.06	2.13	2.56	2.13	2.34
EPS (Diluted)	2.78	2.63	1.79	2.12	1.74	1.88
EPS Growth	38.31%	46.93%	-15.57%	21.84%	-7.45%	184.85%
Free Cash Flow	25.82	20.5	15.3	15.23	14.36	11.03
Free Cash Flow Per Share	3.75	3.04	2.27	2.26	2.18	1.71
Gross Margin	89.43%	89.76%	92.50%	88.45%	91.31%	88.83%
Operating Margin	34.36%	32.15%	30.35%	36.67%	41.35%	32.68%
Profit Margin	32.92%	30.19%	25.27%	32.48%	36.28%	46.03%
Free Cash Flow Margin	39.20%	30.07%	27.00%	28.72%	37.19%	33.66%
Effective Tax Rate	14.16%	14.59%	19.03%	11.48%	15.04%	-40.96%
EBITDA	25.91	24.7	18.28	20.08	17.06	11.33
EBITDA Margin	39.33%	36.22%	32.25%	37.87%	44.20%	34.59%
Depreciation & Amortization	0.65	0.6	0.59	0.63	0.58	0.63
EBIT	25.27	24.1	17.69	19.46	16.49	10.7
EBIT Margin	38.35%	35.35%	31.21%	36.69%	42.71%	32.66%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).